Reuters logo
BRIEF-Aspen Pharmacare says headline earnings rose 21% to 788 cents
September 11, 2013 / 10:44 AM / 4 years ago

BRIEF-Aspen Pharmacare says headline earnings rose 21% to 788 cents

JOHANNESBURG, Sept 11 (Reuters) - Aspen Pharmacare Holdings Ltd : * Headline earnings per share increased 21% to 788,0 cents * Revenue from continuing operations increased 27% to R19,3 billion * Total distribution to shareholders of 157 cents per share * Debt levels will initially be close to self-imposed limits, but gearing

expected to fall through strong cash flows * Ngaged in a major debt raising and restructure exercise to support the

impending transactions * Well positioned to extend the solid performance achieved in the past year

through organic growth

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below